EUPATI Guidance for Patient Involvement in HTA
This guidance helps patients and their representatives get involved in the assessment of health technologies, such as new medicines. It explains how patients can share their views and experiences with decision-makers to make sure patient perspectives are included in health technology assessment (HTA) processes across Europe.
At a glance
Use when
Designing or improving patient involvement strategies in HTA; training patient advocates; informing HTA policy development
Avoid when
When binding regulatory decisions are required; when patient input is not permitted under national law
Inputs
Patient experiences, preferences, and input; existing HTA processes and policies
Outputs
Recommendations for patient involvement in HTA; guidance for HTA bodies and patient advocates
How it works
Developed by the European Patients' Academy on Therapeutic Innovation (EUPATI), this guidance outlines recommendations for integrating patient involvement in HTA processes, focusing on interactions between patients, HTA bodies, and decision-makers. It draws on published research, consensus-building, and good practice examples from European HTA bodies to support meaningful patient engagement. The guidance is non-prescriptive and designed to be adapted to national and regional contexts, legal frameworks, and specific HTA procedures.
- HTA domains
- Organisational aspects, Patient and Social Aspects, Aspects Beyond HTA
- Assumptions
- Patient involvement improves the quality and legitimacy of HTA decisions; patient perspectives provide valuable insights beyond clinical and economic data
- Strengths
- Based on consensus and real-world practices; developed with input from patients and experts; adaptable to different national contexts
- Limitations
- Not legally binding; implementation varies across countries; limited influence in HTA systems with minimal patient engagement infrastructure
- Also known as
- EUPATI HTA Patient Involvement Guidance, EUPATI Guidance on Patient Involvement in Health Technology Assessment
Questions this answers
- › How can patients and their representatives engage with HTA bodies?
- › What are best practices for meaningful patient involvement in HTA?
- › What role do patient perspectives play in assessing health technologies?
- › How can HTA processes better incorporate patient experiences and preferences?
- › What support mechanisms exist for patient participation in HTA across Europe?
- › What are the current barriers to patient involvement in HTA and how can they be addressed?
References & sources
Similar by meaning
- Patients' Perspectives in HTA: A Route to Robust Evidence and Fair Deliberation
- PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION
- Roadmap for Sustaining Meaningful Patient Engagement
- RedETS decisional flowchart for meaningful patient involvement in HTA
- Three-Domain Impact Framework for patient involvement in HTA
Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.